Annual Book Value
$5.37 B
-$2.13 B-28.42%
December 31, 2024
Summary
- As of February 6, 2025, TEVA annual book value is $5.37 billion, with the most recent change of -$2.13 billion (-28.42%) on December 31, 2024.
- During the last 3 years, TEVA annual book value has fallen by -$4.91 billion (-47.72%).
- TEVA annual book value is now -81.92% below its all-time high of $29.72 billion, reached on December 31, 2016.
Performance
TEVA Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Book Value
$5.37 B
-$692.00 M-11.41%
December 31, 2024
Summary
- As of February 6, 2025, TEVA quarterly book value is $5.37 billion, with the most recent change of -$692.00 million (-11.41%) on December 31, 2024.
- Over the past year, TEVA quarterly book value has dropped by -$1.91 billion (-26.17%).
- TEVA quarterly book value is now -82.95% below its all-time high of $31.51 billion, reached on September 30, 2016.
Performance
TEVA Quarterly Book Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Book Value Formula
Book Value = Total Assets − Total Liabilities
TEVA Book Value Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -28.4% | -26.2% |
| 3 y3 years | -47.7% | -40.5% |
| 5 y5 years | -61.5% | -46.4% |
TEVA Book Value Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.7% | at low | -47.7% | at low |
| 5 y | 5-year | -61.5% | at low | -61.5% | at low |
| alltime | all time | -81.9% | >+9999.0% | -83.0% | >+9999.0% |
Teva Pharmaceutical Industries Limited Book Value History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $5.37 B(-28.4%) | $5.37 B(-11.4%) |
| Sep 2024 | - | $6.07 B(-4.6%) |
| Jun 2024 | - | $6.36 B(-12.6%) |
| Mar 2024 | - | $7.28 B(-3.0%) |
| Dec 2023 | $7.51 B(-3.8%) | $7.51 B(+8.3%) |
| Sep 2023 | - | $6.93 B(-1.7%) |
| Jun 2023 | - | $7.05 B(-10.3%) |
| Mar 2023 | - | $7.86 B(+0.7%) |
| Dec 2022 | $7.80 B(-24.1%) | $7.80 B(-11.0%) |
| Sep 2022 | - | $8.77 B(-3.0%) |
| Jun 2022 | - | $9.04 B(-3.3%) |
| Mar 2022 | - | $9.34 B(-9.1%) |
| Dec 2021 | $10.28 B(+2.5%) | $10.28 B(-1.8%) |
| Sep 2021 | - | $10.47 B(+1.4%) |
| Jun 2021 | - | $10.32 B(+3.2%) |
| Mar 2021 | - | $10.00 B(-0.3%) |
| Dec 2020 | $10.03 B(-28.2%) | $10.03 B(+4.5%) |
| Sep 2020 | - | $9.59 B(-30.7%) |
| Jun 2020 | - | $13.85 B(+2.4%) |
| Mar 2020 | - | $13.53 B(-3.2%) |
| Dec 2019 | $13.97 B(-5.0%) | $13.97 B(+1.3%) |
| Sep 2019 | - | $13.79 B(-2.4%) |
| Jun 2019 | - | $14.12 B(-4.1%) |
| Mar 2019 | - | $14.73 B(+0.2%) |
| Dec 2018 | $14.71 B(+7.1%) | $14.71 B(+5.8%) |
| Sep 2018 | - | $13.90 B(-1.9%) |
| Jun 2018 | - | $14.18 B(-5.0%) |
| Mar 2018 | - | $14.93 B(+8.7%) |
| Dec 2017 | $13.73 B(-53.8%) | $13.73 B(-45.2%) |
| Sep 2017 | - | $25.05 B(+2.8%) |
| Jun 2017 | - | $24.37 B(-19.8%) |
| Mar 2017 | - | $30.40 B(+2.3%) |
| Dec 2016 | $29.72 B(+12.2%) | $29.72 B(-5.7%) |
| Sep 2016 | - | $31.51 B(+18.8%) |
| Jun 2016 | - | $26.53 B(-1.1%) |
| Mar 2016 | - | $26.82 B(+1.3%) |
| Dec 2015 | $26.48 B(+13.6%) | $26.48 B(+16.4%) |
| Sep 2015 | - | $22.74 B(-1.3%) |
| Jun 2015 | - | $23.04 B(+1.8%) |
| Mar 2015 | - | $22.64 B(-2.9%) |
| Dec 2014 | $23.31 B(+3.3%) | $23.31 B(-1.4%) |
| Sep 2014 | - | $23.63 B(+0.4%) |
| Jun 2014 | - | $23.54 B(+2.5%) |
| Mar 2014 | - | $22.97 B(+1.8%) |
| Dec 2013 | $22.57 B(-0.9%) | $22.57 B(+1.2%) |
| Sep 2013 | - | $22.31 B(+3.7%) |
| Jun 2013 | - | $21.52 B(-5.3%) |
| Mar 2013 | - | $22.71 B(-0.2%) |
| Dec 2012 | $22.77 B(+2.6%) | $22.77 B(-0.7%) |
| Sep 2012 | - | $22.93 B(+0.8%) |
| Jun 2012 | - | $22.75 B(-1.3%) |
| Mar 2012 | - | $23.05 B(+3.9%) |
| Dec 2011 | $22.20 B(+1.1%) | $22.20 B(-2.9%) |
| Sep 2011 | - | $22.86 B(-3.5%) |
| Jun 2011 | - | $23.68 B(+2.7%) |
| Mar 2011 | - | $23.07 B(+5.1%) |
| Dec 2010 | $21.95 B(+14.2%) | $21.95 B(+1.3%) |
| Sep 2010 | - | $21.67 B(+12.1%) |
| Jun 2010 | - | $19.33 B(-1.6%) |
| Mar 2010 | - | $19.65 B(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $19.22 B(+17.9%) | $19.22 B(-0.2%) |
| Sep 2009 | - | $19.26 B(+8.1%) |
| Jun 2009 | - | $17.82 B(+10.4%) |
| Mar 2009 | - | $16.14 B(-1.0%) |
| Dec 2008 | $16.30 B(+18.8%) | $16.30 B(+9.8%) |
| Sep 2008 | - | $14.84 B(-1.5%) |
| Jun 2008 | - | $15.07 B(+4.7%) |
| Mar 2008 | - | $14.40 B(+4.9%) |
| Dec 2007 | $13.72 B(+23.2%) | $13.72 B(+6.2%) |
| Sep 2007 | - | $12.92 B(+7.1%) |
| Jun 2007 | - | $12.06 B(+5.9%) |
| Mar 2007 | - | $11.39 B(+2.2%) |
| Dec 2006 | $11.14 B(+84.4%) | $11.14 B(+5.3%) |
| Sep 2006 | - | $10.58 B(+6.8%) |
| Jun 2006 | - | $9.90 B(+7.4%) |
| Mar 2006 | - | $9.22 B(+52.6%) |
| Dec 2005 | $6.04 B(+12.1%) | $6.04 B(+8.5%) |
| Sep 2005 | - | $5.57 B(+4.8%) |
| Jun 2005 | - | $5.31 B(+0.2%) |
| Mar 2005 | - | $5.30 B(-1.7%) |
| Dec 2004 | $5.39 B(+63.8%) | $5.39 B(+5.7%) |
| Sep 2004 | - | $5.10 B(+13.1%) |
| Jun 2004 | - | $4.51 B(+4.9%) |
| Mar 2004 | - | $4.29 B(+30.6%) |
| Dec 2003 | $3.29 B(+79.8%) | $3.29 B(+37.8%) |
| Sep 2003 | - | $2.39 B(+8.3%) |
| Jun 2003 | - | $2.21 B(+11.3%) |
| Mar 2003 | - | $1.98 B(+8.3%) |
| Dec 2002 | $1.83 B(+32.5%) | $1.83 B(+10.9%) |
| Sep 2002 | - | $1.65 B(+4.1%) |
| Jun 2002 | - | $1.58 B(+9.4%) |
| Mar 2002 | - | $1.45 B(+4.8%) |
| Dec 2001 | $1.38 B(+19.9%) | $1.38 B(+4.5%) |
| Sep 2001 | - | $1.32 B(+5.6%) |
| Jun 2001 | - | $1.25 B(+6.4%) |
| Mar 2001 | - | $1.17 B(+2.0%) |
| Dec 2000 | $1.15 B(+54.1%) | $1.15 B(+5.3%) |
| Sep 2000 | - | $1.09 B(+2.4%) |
| Jun 2000 | - | $1.07 B(+38.5%) |
| Mar 2000 | - | $771.04 M(+3.2%) |
| Dec 1999 | $747.23 M(+13.4%) | $747.23 M(+5.3%) |
| Sep 1999 | - | $709.30 M(+1.8%) |
| Jun 1999 | - | $696.50 M(+3.5%) |
| Mar 1999 | - | $673.20 M(+2.2%) |
| Dec 1998 | $658.80 M(+7.6%) | $658.80 M(-0.5%) |
| Sep 1998 | - | $662.20 M(+3.3%) |
| Jun 1998 | - | $641.00 M(+1.7%) |
| Mar 1998 | - | $630.30 M(+3.0%) |
| Dec 1997 | $612.00 M(+14.6%) | $612.00 M(+14.6%) |
| Dec 1996 | $534.20 M(+10.7%) | $534.20 M(+10.7%) |
| Dec 1995 | $482.50 M(+41.1%) | $482.50 M(+41.1%) |
| Dec 1994 | $342.00 M(+27.9%) | $342.00 M(+27.9%) |
| Dec 1993 | $267.50 M(+20.3%) | $267.50 M(+20.3%) |
| Dec 1992 | $222.30 M(+21.9%) | $222.30 M(+21.9%) |
| Dec 1991 | $182.40 M(+34.5%) | $182.40 M(+34.5%) |
| Dec 1990 | $135.60 M(+13.6%) | $135.60 M(+13.6%) |
| Dec 1989 | $119.40 M(+20.5%) | $119.40 M(+20.5%) |
| Dec 1988 | $99.10 M(+71.5%) | $99.10 M(+71.5%) |
| Mar 1987 | $57.80 M(+15.8%) | $57.80 M(+15.8%) |
| Mar 1986 | $49.90 M | $49.90 M |
FAQ
- What is Teva Pharmaceutical Industries Limited annual book value?
- What is the all time high annual book value for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual book value year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly book value?
- What is the all time high quarterly book value for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly book value year-on-year change?
What is Teva Pharmaceutical Industries Limited annual book value?
The current annual book value of TEVA is $5.37 B
What is the all time high annual book value for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual book value is $29.72 B
What is Teva Pharmaceutical Industries Limited annual book value year-on-year change?
Over the past year, TEVA annual book value has changed by -$2.13 B (-28.42%)
What is Teva Pharmaceutical Industries Limited quarterly book value?
The current quarterly book value of TEVA is $5.37 B
What is the all time high quarterly book value for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly book value is $31.51 B
What is Teva Pharmaceutical Industries Limited quarterly book value year-on-year change?
Over the past year, TEVA quarterly book value has changed by -$1.91 B (-26.17%)